Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
批准号:
8707985
负责人:
DREW M. PARDOLL
金额:
$54.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-02 至 2015-07-31
关键词:
AccountingAcuteAffectAgeAnaerobic BacteriaAnimal ModelBacteriaBacteroides fragilisCancer ControlCancer EtiologyCancer PatientCellsCessation of lifeChronicClinicalColitisColonColon CarcinomaColonic NeoplasmsCrohn&aposs diseaseDNA DamageDendritic CellsDetectionDevelopmentE-CadherinEpithelialEtiologyExposure toFecesFigs - dietaryFundingGene MutationGenesHelicobacter pyloriHomeostasisHumanImmuneImmune responseImmune systemIncidenceIndiumInflammatoryInflammatory Bowel DiseasesInterleukin-17LeadMalignant NeoplasmsMetalloproteasesModelingMorbidity - disease rateMucosal Immune ResponsesMusMutant Strains MiceNested Case-Control StudyOncogenicPathogenesisPathway interactionsPatientsPeptic UlcerPrevention approachPrevention therapyProductionPublic HealthRaceResearch DesignSerologic testsSignal TransductionSolidT-Lymphocyte SubsetsTestingTimeToxinTumor Suppressor ProteinsUlcerative ColitisUnited StatesWomanbasec-myc Genescarcinogenesiscolon carcinogenesisexperiencemalignant stomach neoplasmmenmicrobialmortalitynovel diagnosticsnovel therapeuticspathogenpromoterprotein Epublic health relevancerepositoryresponsesensorsexsocioeconomicstumortumorigenesis
中文摘要
描述(由申请人提供):我们已经确定了一种人类结肠厌氧细菌,产肠毒素的脆弱拟杆菌(ETBF),作为结肠癌的候选病原,我们的ETBF定植的小鼠模型描绘了ETBF诱导的潜在的致癌前免疫途径。正如幽门螺杆菌的发现改变了对消化性溃疡疾病和随之而来的胃癌的认识一样,我们假设ETBF通过分泌强效的脆弱杆菌毒素(BFT),沉淀癌前黏膜免疫反应,从而促进结肠癌的形成。我们的模型并不建议改变现有的结肠癌突变模式,而是提出ETBF定殖是结肠癌发生所需的基因突变积累的完整机制。该提案将研究ETBF在人类结肠定殖,特定结肠免疫反应和最终结肠癌之间的关系。确定结肠癌的微生物病因具有重要意义,因为结肠癌是一个主要的公共卫生问题,是美国男性和女性癌症死亡的第二大原因。任何两个研究变量(ETBF定植、结肠免疫反应和结肠癌)之间的显著相关性将实质性地改变目前结肠癌发病机制、预防和治疗的范式。
英文摘要
DESCRIPTION (provided by applicant): We have identified a human colon anaerobic bacterium, enterotoxigenic Bacteroides fragilis (ETBF), as a candidate etiologic agent for colon cancer and our murine models of ETBF colonization delineate a potential procarcinogenic immune pathway that ETBF induce. Just as the understanding of peptic ulcer disease and ensuing stomach cancer was transformed by the discovery of H. pylori, we hypothesize that ETBF, by secreting the potent B. fragilis toxin (BFT), precipitate procarcinogenic mucosal immune responses, thereby promoting formation of colon cancer. Our model does not propose to alter existing mutational paradigms of colon cancer but rather proposes that ETBF colonization is an integral mechanism accounting for the accumulation of genetic mutations necessary for colon carcinogenesis. This proposal will study the relationship between colon colonization by ETBF in humans, specific colon immune responses and, ultimately, colon cancer. Defining a microbial etiology for colon cancer has key implications as colon cancer is a major public health problem being the second leading cause of cancer death in the United States in women and men. A significant correlation between any two of the studied variables - ETBF colonization, colon immune responses and colon cancer -- will substantively alter current paradigms for the pathogenesis, prevention and therapy of colon cancer.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1080/19490976.2015.1121363
发表时间:
2016-01-01
期刊:
GUT MICROBES
影响因子:
12.2
作者:
[Dejea, Christine M., Sears, Cynthia L.]
通讯作者:
Sears, Cynthia L.
DOI:
10.1038/ncomms5498
发表时间:
2014-07-24
期刊:
NATURE COMMUNICATIONS
影响因子:
16.6
作者:
[Dutilh, Bas E., Cassman, Noriko, McNair, Katelyn, Sanchez, Savannah E., Silva, Genivaldo G. Z., Boling, Lance, Barr, Jeremy J., Speth, Daan R., Seguritan, Victor, Aziz, Ramy K., Felts, Ben, Dinsdale, Elizabeth A., Mokili, John L., Edwards, Robert A.]
通讯作者:
Edwards, Robert A.
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
-
批准号:10547779
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2018
-
负责人:DREW M. PARDOLL
-
依托单位:
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
-
批准号:10330418
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2018
-
负责人:DREW M. PARDOLL
-
依托单位:
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
-
批准号:10331033
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2018
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:8490291
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8657874
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:8683077
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8105255
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
PD-1/PD-L1 modulation in cancer therapy
-
批准号:10355495
-
项目类别:
-
资助金额:$58.81万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
PD-1/PD-L1 modulation in cancer therapy
-
批准号:9188057
-
项目类别:
-
资助金额:$48.83万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
-
批准号:8137121
-
项目类别:
-
资助金额:$52.15万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:8289608
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
-
批准号:8303450
-
项目类别:
-
资助金额:$57.03万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8455705
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:7947180
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8247110
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
-
批准号:8508195
-
项目类别:
-
资助金额:$48.7万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:8100380
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
PD-1/PD-L1 modulation in cancer therapy
-
批准号:10588130
-
项目类别:
-
资助金额:$60.01万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o
-
批准号:7727553
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2009
-
负责人:DREW M. PARDOLL
-
依托单位:
Developmental Research Program
-
批准号:7727562
-
项目类别:
-
资助金额:$10.6万
-
财政年份:2009
-
负责人:DREW M. PARDOLL
-
依托单位:
海外基金